TP53 and bladder transitional cell carcinoma: In TP53 truncating vs nontruncating mutation cancers, the KEGG data indicated that TP53 positively regulated RIG-I-like receptor signal pathway [27] and cytosolic DNA-sensing pathway [28, 29] in BLCA and OV.